Key terms
About HCAT
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest HCAT news
Mar 05
6:06am ET
Buy Rating on Health Catalyst: Strategic Innovation and Client Growth Poised to Drive Performance
Mar 05
3:15am ET
Barclays Issues a Buy Rating on Health Catalyst (HCAT)
Feb 26
7:36am ET
RBC Capital Remains a Hold on Health Catalyst (HCAT)
Feb 26
6:35am ET
Maintaining Buy Rating on Health Catalyst: Strong Sales Pipeline and Margin Outlook Offset Slower Growth Forecast
Feb 23
8:29am ET
Health Catalyst price target lowered to $15 from $17 at Piper Sandler
Feb 23
7:49am ET
Optimistic Outlook: Health Catalyst’s Growth and Profitability Potential Affirm Buy Rating
Feb 23
7:33am ET
Stifel Nicolaus Remains a Hold on Health Catalyst (HCAT)
Feb 23
7:33am ET
Piper Sandler Sticks to Their Buy Rating for Health Catalyst (HCAT)
Feb 23
7:17am ET
Health Catalyst price target lowered to $11 from $12 at Canaccord
Feb 23
3:05am ET
Health Catalyst (HCAT) Receives a Buy from Barclays
Feb 22
4:33pm ET
Health Catalyst Executive Team Undergoes Major Reshuffle
Feb 22
4:09pm ET
Health Catalyst reports Q4 adjusted EPS 2c, consensus 0c
Feb 21
8:30am ET
Health Catalyst’s Abe Health Registry receives QPP approval
Feb 15
3:20am ET
Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Regeneron (REGN) and Merck & Company (MRK)
Feb 07
8:41am ET
Stifel Nicolaus Sticks to Its Hold Rating for Health Catalyst (HCAT)
Jan 26
9:33am ET
Tesla downgraded, Coinbase upgraded: Wall Street’s top analyst calls
Jan 26
4:50am ET
Analysts Conflicted on These Healthcare Names: Karuna Therapeutics (KRTX) and Health Catalyst (HCAT)
Jan 26
4:46am ET
Health Catalyst upgraded to Buy from Neutral at Guggenheim
Jan 10
7:18am ET
Health Catalyst (HCAT) Gets a Buy from Piper Sandler
Jan 10
7:08am ET
Health Catalyst price target raised to $17 from $12 at Piper Sandler
Jan 09
7:17am ET
Health Catalyst: A Strong Buy on Robust Earnings and Strategic Cost Management
Jan 07
5:34am ET
BTIG Sticks to Their Buy Rating for Health Catalyst (HCAT)
Jan 04
5:38am ET
‘Profitability Is the Key:’ Barclays Says These 3 Health Tech Stocks Are Poised for Growth
Jan 03
6:23am ET
Health Catalyst upgraded to Outperform at Evercore ISI on IT demand inflection
Jan 03
6:19am ET
Barclays starts healthcare technology, distribution with Neutral view
Jan 03
6:16am ET
Health Catalyst upgraded to Outperform from In Line at Evercore ISI
Jan 02
5:03pm ET
Health Catalyst initiated with an Overweight at Barclays
Jan 02
9:21am ET
BTIG Reaffirms Their Buy Rating on Health Catalyst (HCAT)
Dec 31
5:12am ET
Health Catalyst (HCAT) Receives a Buy from BTIG
Dec 22
7:29am ET
Health Catalyst price target raised to $12 from $11 at Piper Sandler
Dec 13
5:15am ET
Health Catalyst just upgraded at JPMorgan, here’s why
No recent press releases are available for HCAT
HCAT Financials
Key terms
Ad Feedback
HCAT Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
HCAT Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
